October 2019
This month's articles take a look back at treatments that have been or are still used, but that don't have the strongest evidence as you might expect. Here are the landmark articles for treatments used in alcoholic hepatitis and contrast…
Morning Report – Renal Failure
Determine AKI on CKD vs CKD AKI: Cr > 0.3 BL in 48hrs, >1.5x BL in 7 days, UO dec by 3cc/kg over 6hrs CKD: GFR 60-90 AND evidence kidney dysfunction, or GFR <60 Before consulting renal get UA, urine…
Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia
Dig deep for that kidney knowledge! Let's quickly review: Arginine vasopressin, otherwise known as antidiuretic hormone (ADH), acts on V2 receptors in the renal distal convoluted tubules to concentrate the urine to maintain water homeostasis. It is implicated in the…
March 2019
This month we touch on topics about hypertension and kidney diseases. Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia Clinical Trial of the Effects of Dietary Patterns on Blood Pressure (DASH)
Now in Nephrology Clinic
Quick Links
August 2018
This month's articles focus on pharmacotherapy for two common diseases in Cardiology and Nephrology: Heart Failure with Reduced Ejection Fraction (HFrEF) and Diabetic Nephropathy. COMET: Comparing beta-blocker to beta-blocker RENAAL: Addition of Angiotensin II receptor blockers (ARB) to antihypertensive therapy
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Clinical Question: As compared to placebo, does the angiotensin-II-receptor agonist (ARB) losartan delay progression to ESRD and improve mortality in patients with type 2 diabetes and nephropathy?
Subspecialty Medicine at Olive View
You may elect to rotate on a subspecialty service at Olive View, including the core subspecialty rotations as well as additional subspecialties like Endocrinology or Sleep Medicine. For more information about each subspecialty, select the rotation below. Cardiology Endocrinology Gastroenterology…
Correction of Anemia with Epoetin Alfa
Anemia is a common complication of chronic kidney disease which is typically treated with recombinant human erythropoietin. However the ideal goal hemoglobin is not well established. This study looks to answer if a lower-goal hemoglobin CKD patients shows decreased adverse…